-
Mar 1996
HLA-DQB1 codon 57 is critical for peptide binding and recognition.
J Exp MedKwok WW, Domeier ME, Johnson ML, Nepom GT, Koelle DM -
Mar 1996
Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis.
J Rheumatol SupplNepom GT, Gersuk V, Nepom BS -
Dec 1995
Polyglot and polymorphism. An HLA update.
Arthritis RheumNepom BS, Nepom GT -
Dec 1995
Glutamic acid decarboxylase and other autoantigens in IDDM.
Curr Opin ImmunolNepom GT -
Sep 1995
Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1.
Mol Cell BiolBeaty JS, West KA, Nepom GT -
Sep 1995
HLA-DQ polymorphisms are highly selective for peptide binding interactions.
J ImmunolKwok WW, Nepom GT, Raymond FC -
Aug 1995
Ultrastructural allelic variation in HLA-DQB1 promoter elements.
Hum ImmunolLeech N, Sorrentino R, McCulloch DK, Nepom GT -
Jul 1995
Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.
J Clin InvestKovats S, Nepom GT, Coleman M, Nepom BS, Kwok WW, Blum JS -
Jul 1995
The prevention of IDDM. Injecting insulin into the cytokine network.
DiabetesGladstone P, Nepom GT -
Jun 1995
Defective CD4+ T-lymphocyte reconstitution in major histocompatibility complex class II-deficient transplant models.
BloodHuss R, Nepom GT, Deeg HJ -
Feb 1995
Differential transcription elements direct expression of HLA-DQ genes.
Clin Immunol ImmunopatholWoolfrey AE, Nepom GT -
Jan 1995
Genetic and immunological markers of insulin dependent diabetes in Black Americans.
AutoimmunityLeech NJ, Kitabchi AE, Gaur LK, Hagopian WA, Hansen J, Burghen GA, Palmer JP, Nepom GT -
Jan 1995
Differential expression of HLA-DQB1 alleles in a heterozygous cell line.
ImmunogeneticsNepom GT, Chung J, West KA -
Jan 1995
Class II antigens and disease susceptibility.
Annu Rev MedNepom GT -
Jan 1995
Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors.
J Immunother Emphasis Tumor ImmunolHock RA, Reynolds BD, Tucker-McClung CL, Kwok WW